Maturitas
Volume 61, Issue 4 , Pages 305-309 , 20 December 2008

Hormone replacement therapy use and the risk of stroke

  • Christel Renoux

      Affiliations

    • McGill Pharmacoepidemiology Research Unit, Jewish General Hospital, Departments of Epidemiology and Biostatistics and of Medicine, McGill University, Montreal, Canada
  • ,
  • Sophie Dell’Aniello

      Affiliations

    • McGill Pharmacoepidemiology Research Unit, Jewish General Hospital, Departments of Epidemiology and Biostatistics and of Medicine, McGill University, Montreal, Canada
  • ,
  • Edeltraut Garbe

      Affiliations

    • Department of Clinical Epidemiology, Bremen Institute for Prevention Research and Social Medicine, University of Bremen, Germany
  • ,
  • Samy Suissa

      Affiliations

    • McGill Pharmacoepidemiology Research Unit, Jewish General Hospital, Departments of Epidemiology and Biostatistics and of Medicine, McGill University, Montreal, Canada
    • Corresponding Author InformationCorresponding author at: Center for Clinical Epidemiology, Jewish General Hospital, 3755 côte Sainte-Catherine, Montreal, Québec, Canada H3T 1E2. Tel.: +1 514 340 8222; fax: + 1 514 340 7564.

Received 19 February 2008 ,Revised 4 September 2008 ,Accepted 20 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0378-5122(08)00254-5

doi: 10.1016/j.maturitas.2008.09.020

Maturitas
Volume 61, Issue 4 , Pages 305-309 , 20 December 2008